Next Article in Journal
Distinctive Distribution of Secretory Phospholipases A2 in the Venoms of Afro-Asian Cobras (Subgenus: Naja, Afronaja, Boulengerina and Uraeus)
Previous Article in Journal
Developmental Toxicity of Mycotoxin Fumonisin B1 in Animal Embryogenesis: An Overview
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Toxins
Volume 11
Issue 2
10.3390/toxins11020115
toxins-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Toxins 2018, 10(12), 535.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Field, M. et al. AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients

by
Malgorzata Field
1,
Andrew Splevins
1,
Philippe Picaut
2,
Marcel van der Schans
3,
Jan Langenberg
3,
Daan Noort
3,
Daniel Snyder
4 and
Keith Foster
1,*
1
Ipsen Bioinnovation, Abingdon OX14 4RY, UK
2
Ipsen Pharma, Cambridge, MA 02142, USA
3
TNO—CBRN Protection, 2288GJ Rijswijk, The Netherlands
4
Ipsen Biopharmaceuticals, Basking Ridge, NJ 07920, USA
*
Author to whom correspondence should be addressed.
Toxins 2019, 11(2), 115; https://doi.org/10.3390/toxins11020115
Submission received: 12 February 2019 / Accepted: 13 February 2019 / Published: 13 February 2019
Versions Notes
The authors wish to make the following corrections to their paper [1].
Daniel Snyder should be listed as the author of their paper and the fourth affiliation “Ipsen Biopharmaceuticals, Basking Ridge, NJ 07920, USA; [email protected]” should be added.
In the first affiliation, the original email address of Malgorzata Field is [email protected]. This correct email address should be replaced by [email protected]
The “Author Contribution” section should be replaced by “Conceptualisation, M.F., A.S., P.P., D.S. and K.F.; Formal analysis, M.F., M.v.d.S., J.L. and D.N.; Investigation, M.F. and M.v.d.S.; Methodology, M.F., A.S., P.P., K.F. and M.v.d.S.; Validation, M.F., M.v.d.S., J.L. and D.N.; Visualisation, M.F., M.v.d.S., J.L. and D.N.; Writing—review & editing, M.F., A.S., P.P., M.v.d.S., J.L., D.N. and K.F. M.v.d.S., J.L. and D.N. were only involved in the EndoPep analyses.”
The “Conflicts of Interest” section should be replaced by “A.S., K.F. and P.P. are employed by Ipsen Pharma. D.S. and M.F. are ex-employees of Ipsen Pharma. M.v.d.S., J.L. and D.N. are employed by TNO.”
The manuscript will be updated and the original will remain online on the article webpage. We apologize for any inconvenience caused to our readers.

Reference

  1. Field, M.; Splevins, A.; Picaut, P.; Van der Schans, M.; Langenberg, J.; Noort, D.; Foster, K. AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients. Toxins 2018, 10, 535. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Field, M.; Splevins, A.; Picaut, P.; van der Schans, M.; Langenberg, J.; Noort, D.; Snyder, D.; Foster, K. Correction: Field, M. et al. AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients. Toxins 2019, 11, 115. https://doi.org/10.3390/toxins11020115

AMA Style

Field M, Splevins A, Picaut P, van der Schans M, Langenberg J, Noort D, Snyder D, Foster K. Correction: Field, M. et al. AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients. Toxins. 2019; 11(2):115. https://doi.org/10.3390/toxins11020115

Chicago/Turabian Style

Field, Malgorzata, Andrew Splevins, Philippe Picaut, Marcel van der Schans, Jan Langenberg, Daan Noort, Daniel Snyder, and Keith Foster. 2019. "Correction: Field, M. et al. AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients" Toxins 11, no. 2: 115. https://doi.org/10.3390/toxins11020115

APA Style

Field, M., Splevins, A., Picaut, P., van der Schans, M., Langenberg, J., Noort, D., Snyder, D., & Foster, K. (2019). Correction: Field, M. et al. AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients. Toxins, 11(2), 115. https://doi.org/10.3390/toxins11020115

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop